or Try an Advanced Search...

    Technical Analysis for ADMA - ADMA Biologics Inc

    Grade Last Price % Change Price Change
    A 6.20 2.65% 0.16
    ADMA closed up 2.65 percent on Thursday, April 18, 2024, on 1.14 times normal volume.
    Earnings due: May 8
    *** please verify all earnings dates ***
    5 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical ADMA trend table...
    Date Alert Name Type % Chg
    Stochastic Buy Signal Bullish 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Inside Day Range Contraction 0.00%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 2.65%
    Strong but Oversold Other 2.65%
    Inside Day Range Contraction 2.65%
    Oversold Stochastic Weakness 2.65%
    Stochastic Reached Oversold Weakness 0.65%
    Strong but Oversold Other 0.65%
    Outside Day Range Expansion 0.65%
    Older End-of-Day Signals for ADMA ...

       Recent Intraday Alerts

    Alert Time
    Up 2% about 9 hours ago
    Rose Above 10 DMA about 9 hours ago
    Possible NR7 about 11 hours ago
    Possible Inside Day about 11 hours ago
    10 DMA Resistance about 11 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ADMA Chart by TradingView
    Basic chart:

    Profile

    ADMA Biologics, Inc., a late stage biopharmaceutical company, develops, manufactures, and intends to market plasma-based biologics for the treatment and prevention of infectious diseases. Its lead product candidate, RI-002, which is in Phase III clinical trial, is intended for the treatment of primary immune deficiency disease. RI-002 is an injectable immune globulin derived from human plasma enriched with high levels of naturally occurring polyclonal antibodies, as well as high levels of antibodies targeted to respiratory syncytial virus. The company also operates ADMA BioCenters, which are plasma collection centers. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Biopharmaceutical Biology Immunology Immune System Infectious Diseases Antibodies Antibody Glycoproteins Polyclonal Antibodies

    Is ADMA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 18 Sage (SAGE) Down 20% on Parkinson's Study Missing Primary Goal
    Apr 17 Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note
    Apr 17 Are Medical Stocks Lagging Annexon (ANNX) This Year?
    Apr 17 GSK Announces FDA Acceptance of New Meningococcal Jab BLA
    Apr 16 Aptevo (APVO) Stock Plummets 79% in a Week: Here's Why
    Apr 16 Marinus (MRNS) Down 83% on Lead Drug Falling Short in Seizure Study
    Apr 16 J&J (JNJ) Q1 Earnings Beat Estimates, Sales Miss, MedTech Soft
    Apr 10 Moderna (MRNA) Up 6% on Upbeat Data From Cancer Jab Study
    Apr 9 Vincerx (VINC) Tumbles on Results From Cancer Therapy Study
    Apr 9 Is it a Good Idea to Invest in ADMA Biologics (ADMA) Stock Now?
    See more ADMA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 6.76
    52 Week Low 3.06
    Average Volume 2,607,073
    200-Day Moving Average 4.46
    50-Day Moving Average 5.90
    20-Day Moving Average 6.29
    10-Day Moving Average 6.14
    Average True Range 0.23
    RSI (14) 52.38
    ADX 19.26
    +DI 14.09
    -DI 15.70
    Chandelier Exit (Long, 3 ATRs) 6.06
    Chandelier Exit (Short, 3 ATRs) 6.58
    Upper Bollinger Bands 6.69
    Lower Bollinger Band 5.88
    Percent B (%b) 0.4
    BandWidth 12.90
    MACD Line 0.03
    MACD Signal Line 0.09
    MACD Histogram -0.0545
    Fundamentals Value
    Market Cap 1.4 Billion
    Num Shares 226 Million
    EPS -0.11
    Price-to-Earnings (P/E) Ratio -56.36
    Price-to-Sales 5.05
    Price-to-Book 7.81
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 6.50
    Resistance 3 (R3) 6.47 6.34 6.45
    Resistance 2 (R2) 6.34 6.26 6.36 6.43
    Resistance 1 (R1) 6.27 6.22 6.31 6.30 6.42
    Pivot Point 6.14 6.14 6.16 6.16 6.14
    Support 1 (S1) 6.07 6.06 6.11 6.10 5.98
    Support 2 (S2) 5.94 6.02 5.96 5.97
    Support 3 (S3) 5.87 5.94 5.95
    Support 4 (S4) 5.90